Factors associated with the failure of first and second-line antiretroviral therapies therapy, a case control study in Cambodian HIV-1 infected children

[1]  D. Reinharz,et al.  Perceived stigma by children on antiretroviral treatment in Cambodia , 2014, BMC Pediatrics.

[2]  Á. Holguín,et al.  Drug resistance in the HIV-1-infected paediatric population worldwide: a systematic review. , 2014, The Journal of antimicrobial chemotherapy.

[3]  S. Walker,et al.  Early infant diagnosis of HIV infection in low-income and middle-income countries: does one size fit all? , 2014, The Lancet. Infectious diseases.

[4]  G. Tessema,et al.  Adherence to antiretroviral therapy and its associated factors among children at South Wollo Zone Hospitals, Northeast Ethiopia: a cross-sectional study , 2014, BMC Public Health.

[5]  P. Reiss,et al.  Long-term Effectiveness of Combination Antiretroviral Therapy and Prevalence of HIV Drug Resistance in HIV-1–infected Children and Adolescents in Rwanda , 2014, The Pediatric infectious disease journal.

[6]  M. Belay,et al.  Adherence to Antiretroviral Therapy and associated factors among HIV infected children in Ethiopia: unannounced home-based pill count versus caregivers’ report , 2013, BMC Pediatrics.

[7]  L. Ferradini,et al.  Increased Risk of Q151M and K65R Mutations in Patients Failing Stavudine-Containing First-Line Antiretroviral Therapy in Cambodia , 2013, PloS one.

[8]  R. Kantor,et al.  Extensive drug resistance in HIV-infected Cambodian children who are undetected as failing first-line antiretroviral therapy by WHO 2010 guidelines. , 2013, AIDS research and human retroviruses.

[9]  R. Kantor,et al.  Prediction of treatment failure using 2010 World Health Organization Guidelines is associated with high misclassification rates and drug resistance among HIV-infected Cambodian children. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  M. Jimba,et al.  High Risk of ART Non-Adherence and Delay of ART Initiation among HIV Positive Double Orphans in Kigali, Rwanda , 2012, PloS one.

[11]  J. Schapiro,et al.  Genotypic impact of prolonged detectable HIV type 1 RNA viral load after HAART failure in a CRF01_AE-infected cohort. , 2011, AIDS research and human retroviruses.

[12]  C. Goujard,et al.  Short communication: three years follow-up of first-line antiretroviral therapy in cambodia: negative impact of prior antiretroviral treatment. , 2011, AIDS research and human retroviruses.

[13]  L. Ferradini,et al.  Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV‐infected patients in Cambodia , 2011, Tropical medicine & international health : TM & IH.

[14]  P. Rosenthal,et al.  Early Virologic Failure and the Development of Antiretroviral Drug Resistance Mutations in HIV-Infected Ugandan Children , 2011, Journal of acquired immune deficiency syndromes.

[15]  L. Ferradini,et al.  High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia , 2011, Journal of the International AIDS Society.

[16]  R. Zachariah,et al.  High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia , 2010, Journal of the International AIDS Society.

[17]  M. Somasundaran,et al.  Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy (HAART). , 2010, The Southeast Asian journal of tropical medicine and public health.

[18]  R. Walensky,et al.  Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  R. Zachariah,et al.  Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: a cohort study from Cambodia , 2009, BMC pediatrics.

[20]  D. Prybylski,et al.  Survival and quality of life among HIV-positive people on antiretroviral therapy in Cambodia. , 2009, AIDS patient care and STDs.

[21]  Arjan de Wagt,et al.  Evidence base for children affected by HIV and AIDS in low prevalence and concentrated epidemic countries: applicability to programming guidance from high prevalence countries , 2009, AIDS care.

[22]  N. Ford,et al.  Effectiveness of Highly Active Antiretroviral Therapy in HIV-Positive Children: Evaluation at 12 Months in a Routine Program in Cambodia , 2007, Pediatrics.

[23]  C. Rouzioux,et al.  Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia , 2007, AIDS.